BROADWOOD CAPITAL INC - Q3 2019 holdings

$720 Million is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 28.6% .

 Value Shares↓ Weighting
STAA  STAAR SURGICAL CO$279,471,000
-12.3%
10,840,6300.0%38.80%
-2.6%
MNST  MONSTER BEVERAGE CORP NEW$271,681,000
-9.0%
4,679,3080.0%37.71%
+1.0%
IWM  ISHARES TRrussell 2000 etf$63,563,000
-2.7%
420,0000.0%8.82%
+8.1%
AXON  AXON ENTERPRISE INC$43,156,000
-11.6%
760,0620.0%5.99%
-1.8%
LCTX NewLINEAGE CELL THERAPEUTICS IN$33,325,00034,005,379
+100.0%
4.63%
OCX BuyONCOCYTE CORPORATION$23,306,000
+15.6%
11,098,267
+37.0%
3.24%
+28.3%
AGE  AGEX THERAPEUTICS INC$5,874,000
-46.6%
2,997,1560.0%0.82%
-40.7%
BTX ExitBIOTIME INC$0-33,980,826
-100.0%
-4.67%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14
42023-11-09
42023-11-06

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Export BROADWOOD CAPITAL INC's holdings